Physician

Geover Fernandez, MD

According to 2025 Medicare claims, Geover Fernandez, MD (NPI: 1639103138) practices dermatology in the Bakersfield-Delano, CA market, with the plurality of this provider's patient population coming from Kern, CA. This provider's primary affiliated billing organization is RAVI PATEL M.D. INC (NPI: 1912978834; TIN: 770356364) and primary practice location at 93309-0633.

Fernandez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,314 traditional Medicare patients, billed 19,400 HCPCS/CPT codes, and received $1,902,982 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 896 prescription claims across 372 beneficiaries totaling $318,468 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 78 records totaling $1,688. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,011,480 to $1,902,982. Similarly, Part D prescription costs have risen steadily, from $82,812 to $318,468. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$951K$1.9M2015 Medicare payment: $1,011,480 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $980,374 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,099,256 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,164,504 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,147,441 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,003,970 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,439,227 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,513,143 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,544,450 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,902,982 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1607,660$1,011,480
20161,3098,756$980,374
20171,35910,247$1,099,256
20181,54310,803$1,164,504
20191,68611,943$1,147,441
20201,60811,111$1,003,970
20211,74514,068$1,439,227
20221,90115,605$1,513,143
20232,01115,702$1,544,450
20242,31419,400$1,902,982

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$316K$632K2015 Drug cost: $82,812 (USD; Tot_Drug_Cst)2016 Drug cost: $102,146 (USD; Tot_Drug_Cst)2017 Drug cost: $337,315 (USD; Tot_Drug_Cst)2018 Drug cost: $390,441 (USD; Tot_Drug_Cst)2019 Drug cost: $448,841 (USD; Tot_Drug_Cst)2020 Drug cost: $297,549 (USD; Tot_Drug_Cst)2021 Drug cost: $447,363 (USD; Tot_Drug_Cst)2022 Drug cost: $631,618 (USD; Tot_Drug_Cst)2023 Drug cost: $497,729 (USD; Tot_Drug_Cst)2024 Drug cost: $318,468 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015212497$82,812
2016271660$102,146
2017293756$337,315
2018407992$390,441
2019290790$448,841
20203621,080$297,549
20213831,177$447,363
20223691,066$631,618
2023333873$497,729
2024372896$318,468

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth8141,111$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0151,814$68
88305Pathology examination of tissue using a microscope, intermediate complexity1,6404,467$56
11103Biopsy of related skin growth, each additional growth4681,113$42
17000Destruction of precancer skin growth, 1 growth553748$35

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab13364$47,049
CalcipotrieneCalcipotriene31853$6,736
FluorouracilFluorouracil661,791$5,218
Doxycycline HyclateDoxycycline Hyclate1354,411$3,489
FluocinonideFluocinonide682,235$2,942

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.78$1,688ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Geover Fernandez, MD?

Tedicare shows public-source Medicare data for Geover Fernandez, MD (NPI 1639103138), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Geover Fernandez, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Geover Fernandez, MD?

Geover Fernandez, MD is linked to RAVI PATEL M.D. INC (billing NPI 1912978834) in the available physician profile data.

Does Geover Fernandez, MD have Open Payments data?

Geover Fernandez, MD has 78 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.